ClinicalTrials.gov
public full text
Public Domain
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
The purpose of this study is to evaluate the efficacy and safety of adding Symlin to an established regimen of insulin glargine in subjects with type 2 diabetes who are not achieving glycemic targets.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)#28529
- Factores y barreras que influyen en la adherencia al tratamiento nutricional y actividad física en pacientes con diabetes tipo 2#305955
- A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes#321630
- Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients#812389
- Conocimiento y prevención del pie diabético en pacientes con diabetes mellitus Tipo II en un Centro De Salud Chiclayo 2023#276986
Record · ID 1087891
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive